Zobrazeno 1 - 10
of 155
pro vyhledávání: '"O N Minushkin"'
Publikováno v:
Терапевтический архив, Vol 86, Iss 8, Pp 50-55 (2014)
MATERIALS AND METHODS. The investigators examined 30 patients (16 men, 14 women) after gastrectomy (n = 15) or gastric resection (n = 15) who had anacidity as shown by pH-metry and the clinical and/or endoscopic signs of RE. During 4 months, Groups 1
Externí odkaz:
https://doaj.org/article/c8064a7479404981b7cf724c6947aece
Autor:
O N Minushkin
Publikováno v:
Научно-практическая ревматология, Vol 41, Iss 4, Pp 64-67 (2003)
Objective. To study nise efficacy and safety in pts with rheumatic diseases (RD) with concomitant disorders of upper gastrointestinal tract (GIT). Material and methods. An open uncontrolled multicenter nise study was conducted on 600 pts (mean age 54
Externí odkaz:
https://doaj.org/article/b758056df8d84579afb80a585f6caa18
Autor:
O N Minushkin, E G Burdina
Publikováno v:
Терапевтический архив, Vol 79, Iss 1, Pp 26-28 (2004)
Aim. To study the role of Helicobacter pylori (HP) persistance in generation of gastric mucosa adenoma. Material and methods. Esophagogastroduodenoscopy with biopsy of the mucosa from the antral portion and body of the stomach was made for diagnosis
Externí odkaz:
https://doaj.org/article/e78d96cf347647adb89be399dd7ee516
Publikováno v:
Терапевтический архив, Vol 92, Iss 8, Pp 18-23 (2020)
Aim. Тo evaluate the modern view on the problem of chronic gastritis and the effectiveness of the drug ursodexic acid (UHC) Grinterol in the treatment of patients with chronic antral reflux-gastritis (biliar). Materials and methods. The work prov
Externí odkaz:
https://doaj.org/article/697e499c77c040efb9c43ff41be132c9
Autor:
O. N. Minushkin, T. L. Pilate, L. V. Maslovskii, A. A. Frolova, M. I. Bulanova, Ju. S. Skibina, V. S. Inevatova, I. V. Zverkov
Publikováno v:
Meditsinskiy sovet = Medical Council. :87-95
Introduction. Dietary nutrition is a physiological therapeutic and prophylactic approach for chronic pancreatitis during an exacerbation. Given the acute reaction of patients to various foods, specialized dietary products designed specifically for th
Autor:
O. N. Minushkin, I. V. Zverkov, L. V. Maslovskii, V. S. Inevatova, Yu. G. Kuznetsova, T. L. Pilat
Publikováno v:
Meditsinskiy sovet = Medical Council. :126-133
Introduction. Dietary nutrition is one of the most important and physiological therapeutic and preventive approaches for chronic reflux gastritis (CRG), not associated with HP infection. Aim. To analyze the effectiveness and safety of the use of spec
Autor:
O. N. Minushkin, L. V. Maslovsky, A. A. Frolova, T. S. Shindina, M. I. Bulanova, K. S. Legkova
Publikováno v:
Experimental and Clinical Gastroenterology. :82-88
Aim of investigation: to evaluate the effectiveness and safety of the use of dietary supplement "Tummy ease" in the treatment of patients with functional constipation and IBS with a predominance of constipation. Materials and methods: The treatment o
Autor:
T. L. Pilat, O. N. Minushkin, L. B. Lazebnik, I. V. Zverkov, Yu. G. Kuznetsova, R. A. Khanferyan
Publikováno v:
Meditsinskiy sovet = Medical Council. :46-61
This review of the literature is devoted to the importance of nutritional support in the treatment and prevention of diseases of the gastrointestinal tract associated with Helicobacter pylori. Modern data on the biological properties of H. pylori and
Publikováno v:
Meditsinskiy sovet = Medical Council. :109-115
Introduction. Diverticular disease of the colon is one of the most common gastrointestinal diseases. During the last 30–40 years, there has been a “rejuvenation” of the disease. Today, the prevalence of the disease in people under 40 years of a
Autor:
O. N. Minushkin, L. V. Maslovsky, M. D. Ardatskaya, M. I. Bulanova, N. I. Beilina, A. M. Kolodkin, I. V. Zverkov, E. S. Gordienko
Publikováno v:
Experimental and Clinical Gastroenterology. :100-108
Aim of investigation: to assess the effectiveness and tolerance of dietary supplements (BAA) STIM and STIM LaxMaterials and methods: The analysis of the treatment of 73 patients who were divided into 2 groups. Group 1-32 patients with functional cons